Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Data is Dominating Wall Street

Host TC Riley kicks off this installment of Diving Into Data, with a deep-dive into the recent data-centric boom on Wall Street. “There’s a data dominance going on. There’s a lot more data related things going on in the stock market than I think we’ve traditionally seen, especially as it relates to the companies…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Host TC Riley kicks off this installment of Diving Into Data, with a deep-dive into the recent data-centric boom on Wall Street. “There’s a data dominance going on. There’s a lot more data related things going on in the stock market than I think we’ve traditionally seen, especially as it relates to the companies themselves,” he said.

Snowflake and JFrog are two of the data companies to go under the magnifying glass. Snowflake is a cloud-based data-warehousing company that decouples storage and computation functions, which basically translates into a more easily controlled relationship between user expectations and costs. JFrog, on the other hand, is a DevOps platform that’s based in cloud functionality. Because of its cloud-based nature, the entire platform is easily customized and facilitates faster software releases.

TC pointed out that this data boom has indications for the future, saying “It’s interesting to see so many data companies that have these huge offerings. I think it points toward more and more people buying into the overall value of data long-term and where the business world is heading.”

On the topic of data companies, TC also talked about the challenges, and opportunities, of data in the healthcare industry. There are a lot of considerations that need to be undertaken in terms of privacy and possible misuse of patient information by, say, insurance companies when it comes to healthcare data, and TC mused about the potential benefits for the good of everyone in the future. “There is an opportunity to transform the way we think about healthcare data, and there’s not a perfect solution here,” he said.

To wrap things up, TC touched on how data could be used to prevent veteran suicides by transitioning from a bottom-up model that utilizes data gathered after tragic incidents to a top-down model that can identify triggers and conditions and preemptively stop the tragedy from happening at all. “I think it’s something we owe our veterans,” said TC.

Catch up on all episodes of Diving Into Data!

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512